Clinical Trial Update: Human Immune Response to Ixodes Scapularis Tick Bites [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update assessing human immune responses to Ixodes scapularis tick bites, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lyme Disease

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Tick-borne Diseases, Tick Resistance | Phase 1, Phase 2 | Status: RECRUITING